Pravastatin Sodium
Product Images NDC 10544-505

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Pravastatin Sodium (NDC 10544-505). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Blenheim Pharmacal, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label 10mg 30ct (Label Pravastatin Tabs 10mg Bpi(10544 440 30) Glenmark(68462 195 05) Rev1)

Pravastatin Sodium Tablets USP 10mg, a bottle label showing 30 tablets by Blenheim Pharmacal, Inc. The label includes storage instructions, NDC number 10544-440-30, manufacturer code 68462-195-05, and usage note indicating prescription only. Dosage directions refer to the package insert.*

FDA Label Image

Label 20mg 30ct (Label Pravastatin Tabs 20mg Bpi(10544 505 30) Glenmark(68462 196 05) Rev0)

Label for Pravastatin Sodium Tablets USP 20 mg, supplied in a 30-count package. The label indicates Rx Only status, with storage instructions specifying room temperature and light-resistant container. Label references Blenheim Pharmacal, Inc. as the repackager and Glenmark Generics Inc. as the manufacturer. Includes NDC 10544-505-30 and lot number BP00000000, with placeholder expiration date 00/00/0000.*

FDA Label Image

Label 40mg 30ct (Label Pravastatin Tabs 40mg Bpi(10544 507 30) Glenmark(68462 197 05) Rev0)

Label for Pravastatin Sodium Tablets USP 40 mg, containing 30 tablets. The label displays the NDC code 10544-507-30, manufacturer code 68462-197-05, and states the product is Rx only. Storage instructions advise keeping at 25°C (77°F) with permitted excursions and in a tight, light-resistant container. The label is from Blenheim Pharmacal, Inc., with repackaging and manufacturing information noted.*

FDA Label Image

Structure (Image 01)

Chemical structure of pravastatin sodium, illustrating its molecular formula with carbon, hydrogen, oxygen, and sodium atoms arranged in the characteristic structure of this active pharmaceutical ingredient.*

FDA Label Image

Figure 2 (Image 02)

A line graph comparing the proportion of subjects without event over 5.5 years since randomization between Placebo and Pravastatin groups. The y-axis shows the proportion of subjects without event, and the x-axis represents years since randomization. Two lines depict Placebo and Pravastatin outcomes, with a statistical significance indicated by Logrank P = 0.0001.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.